Home / Products / Cancer (Tumor) Cell Lines / NCI-H211
NCI-H211
Datasheet Protocol

NCI-H211

Cat. No. ARC0610
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Lung

Growth Properties:

Aggregates in suspension

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

NCI-H211 is a cancer cell line of small cell lung cancer (SCLC), isolated from metastatic; bone marrow.

Recommended Products

ENDOD1 Knockout A2780 Polyclonal Cells ENDOD1 Knockout A2780 Polyclonal Cells Cat. No. ARG18458 CGNL1 Knockout HT29 Polyclonal Cells CGNL1 Knockout HT29 Polyclonal Cells Cat. No. ARG14564 GNPTG Knockout Raji Polyclonal Cells GNPTG Knockout Raji Polyclonal Cells Cat. No. ARG23591 ACSL4 Knockout CaSki Polyclonal Cells ACSL4 Knockout CaSki Polyclonal Cells Cat. No. ARG35424 IGF2 Knockout A549 Polyclonal Cells IGF2 Knockout A549 Polyclonal Cells Cat. No. ARG35624 BLVRB Knockout HAP1 Polyclonal Cells BLVRB Knockout HAP1 Polyclonal Cells Cat. No. ARG37053
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Lung
Disease:
Small cell lung cancer (SCLC)
Morphology:
Round
Growth Mode:
Aggregates in suspension
Age:
50 years
Sex of Donor:
Female
Derived From Site:
Metastatic; Bone marrow
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

MPZL1 Knockout A2780 Polyclonal Cells

MPZL1 Knockout A2780 Polyclonal Cells

Cat. No. ARG18244
 IBTK Knockout HEK293T Polyclonal Cells

IBTK Knockout HEK293T Polyclonal Cells

Cat. No. ARG37861
 HNRNPLL Knockout huh-7 Polyclonal Cells

HNRNPLL Knockout huh-7 Polyclonal Cells

Cat. No. ARG28321
 MAP2K3 Knockout HCT116 Polyclonal Cells

MAP2K3 Knockout HCT116 Polyclonal Cells

Cat. No. ARG7298
 LEF1 Knockout 786-O Polyclonal Cells

LEF1 Knockout 786-O Polyclonal Cells

Cat. No. ARG5193
 HCT 116 Luciferase Stable Cell Line

HCT 116 Luciferase Stable Cell Line

Cat. No. ARG0273